Early clinical trials suggest it may have very potent effects on weight and metabolic markers, but: It is not FDAapproved for weight loss or general wellness
This peptide also exerts effects on appetite as well as gastric emptying
The one-line difference: two receptors versus three Tirzepatide is an approved dual agonist of the GLP-1 and GIP receptors
However, A1C testing during this phase wont yet reflect Retatrutides effects since this marker requires months to change meaningfully
Our approach to personalized care includes: Initial Medical Screening: Before starting, you complete a free assessment quiz that reviews your health history, current BMI, and weight loss goals
If nausea persists, antiemetic medications such as ondansetron may provide symptomatic relief, though this should be discussed with the prescribing physician